Neurovive Pharmaceutical Ab

USPTO Trademark & Patent Filings

Trademark applications and grants for Neurovive Pharmaceutical Ab. Neurovive Pharmaceutical Ab has 7 trademark applications. The latest application filed is for "NEUROVIVE"

Company Profile

NeuroVive Pharmaceutical AB
ab pharmaceutical neurovive
NEUROVIVE PHARMACEUTICAL AB - Lund SE
NeuroVive Pharmaceutical AB - Lund SE

Trademarks Patents

Patent Applications

Patent Application	Date
Use of Sanglifehrin Macrocyclic Analogues as Anticancer Compounds 20190328734 - 16/349757 Gronberg; Alvar ; et al.	2019-10-31
Liver Prodrugs of Mitochondrial Proton Ionophores 20190276481 - 16/348585 Hansson; Magnus Joakim ; et al.	2019-09-12
Novel Cell-Permeable Succinate Compounds 20170105961 - 15/128480 Elmer; Eskil ; et al.	2017-04-20
Prodrugs of Succinic Acid for Increasing ATP Production 20170105960 - 15/128465 Elmer; Eskil ; et al.	2017-04-20
Succinate Prodrugs for Use in the Treatment of Lactic Acidosis or Drug-Induced Side-Effects Due to Complex I-Related Impairment of Mitochondrial Oxidative Phosphorylation 20170100359 - 15/128496 Elmer; Eskil ; et al.	2017-04-13
Cell-permeable succinate compounds 11,147,789 - 15/128,480 Elmer , et al. October 19, 2	2021-10-19
Use of sanglifehrin macrocyclic analogues as anticancer compounds 10,857,150 - 16/349,757 Gronberg , et al. December 8, 2	2020-12-08
Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation 10,307,389 - 15/128,496 Elmer , et al.	2019-06-04
Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation 10,307,389 - 15/128,496 Elmer , et al.	2019-06-04
Dosage form 9,504,728 - 14/348,859 Gregory , et al. November 29, 2	2016-11-29

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"NEUROVIVE" 79250595	NEUROVIVE 2018-11-09
"NP NEUROVIVE PHARMACEUTICAL" 79250939	NP NEUROVIVE PHARMACEUTICAL 2018-11-09
"NP" 79258394	NP 2018-11-09
"TOXPHOS" 4766597 79156896	TOXPHOS 2014-06-19
"NEUROSTAT" 4347704 85555773	NEUROSTAT 2012-02-29
"NEUROVIVE" 3520893 79047227	NEUROVIVE 2007-09-07
"NP" 3524377 79045153	NP 2007-08-31

Company Registrations

SEC

0001643349

NeuroVive Pharmaceutical AB of SWEDEN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.